Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Leukotriene Receptor Antagonists (LTRAs)
Treatment for Allergic Rhinitis
Typical Dosage: 10mg once daily (e.g., Montelukast)
Effectiveness
65%
Safety Score
55%
Clinical Trials
200
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
10mg once daily (e.g., Montelukast)
Time to Effect
1-2 weeks
Treatment Duration
Seasonal or daily as needed
Evidence Quality
MODERATENumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
2000(Treat 2000 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$180
Monitoring:$25
Side Effect Mgmt:$10
Total Annual:$215
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATEQALYs Gained
0.02
Outcome-Based Costs
Cost per Responder
$430
Cost per Remission
$3,071.43
Comparison vs Intranasal Corticosteroids
Cost Difference
$0/year
Same cost
QALY Difference
-0.05 QALYs
Worse outcomes
Dominance
No dominance
Prescription Access Economics
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov